Compared with postoperative stereotactic radiation therapy, an investigational intraoperative RT approach could significantly reduce local tumor recurrence and improve survival in patients with newly diagnosed operable brain metastases.
New findings could shift the standard approach to preventing brain metastases in SCLC, particularly as modern MRI allows clinicians to detect and treat brain disease earlier.
The imaging agent could potentially help doctors characterize a malignancy's aggression and identify lesions with a higher likelihood of invasion or metastasis.
A new review led by UCLA researchers examines the utility of commercially available AI tools for screening mammography and evidence surrounding their ability to detect interval cancers.
The duo plan to establish a global center of excellence in theranostics, taking advantage of Siemens’ state-of-the-art technology and software to advance the use of radiopharmaceuticals in cancer care.
More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
Experts involved in its development are confident the agent has the potential to overcome shortcomings associated with conventional oral agents currently on the market.
